oxfordscienceenterprises.com ↗Activity from announced rounds
Venture building and investment across Oxford’s deep tech, life sciences and health technology ecosystem.
Oxford Science Enterprises builds and funds companies from Oxford’s science ecosystem. It works with university researchers, technology hubs and independent scientific startups, combining company formation with investment from pre-seed through growth. Its stated sectors are deep tech, life sciences and health technology.
Covered financings include Vivid Dx in diagnostics, Mirae in chronic care, ReEmerge in brain-injury rehabilitation, MCatalysis in fuels and events involving Oxford Quantum Circuits and Quantum Motion. These illustrate the range of recorded scientific businesses; OSE’s own directory describes its broader portfolio.
ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.
MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers.
Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions
AI-driven continuous care platform for autoimmune disease and other complex chronic conditions
An agricultural biotechnology company focused on discovering novel mode of action herbicides
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
Develops superconducting quantum computers delivered via cloud for financial services, defence, and research customers
Builds utility-scale quantum computers using industry-standard silicon transistors
Uses Causal AI to reformulate complex small-molecule drugs